BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors

Are you struggling to find investors, funding, collaborators, and strategic connections in the ever-changing world of biotech? This show empowers bio…
Aug 21st, 2024 | 20:50

Episode 49: Optimizing Interactions with Corporate Biotech Companies, featuring Key Opinion Leader Tari Suprapto (RE-RELEASE)

Are you navigating the complexities of forming and maintaining corporate partnerships in biotech?
In this episode, we sit down for a conversation with Tari Suprapto, PhD, the Director of Search and Evaluation at Novo Nordisk, who offers valuable tips on managing relationships between academic and corporate partners (that are also useful for smaller companies looking to interact with larger ones). Host Kaneisha Akinpelumi dives into the importance of personal connections, shared goals, and effective communication in successful partnerships. Dr. Suprapto also shares her experiences dealing with imposter syndrome in high-stakes environments.
In this episode, you'll discover:
  • Strategies for fostering strong academic-corporate partnerships in the biotech sector.
  • The critical role of communication and shared goals in sustaining these relationships.
  • Tari Suprapto’s insights on overcoming imposter syndrome while navigating the biotech industry.

Tune in to gain actionable advice on building and maintaining successful partnerships in biotech.
Links:
Connect with Tari Suprapto, PhD, and learn about Novo Nordisk.
Check out Dr. Suprapto’s BIO on the BAYOU panel: Conversation with Corporate Colleagues.
Connect with Kaneisha Akinpelumi and learn about Xavier University of Louisiana’s Office of Research and Sponsored Programs.
Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.